SK bioscience Co.,Ltd. (KRX:302440)
50,300
-1,000 (-1.95%)
Last updated: Jun 23, 2025
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.76 trillion as of June 27, 2025. Its market cap has decreased by -10.65% in one year.
Market Cap
3.76T
Enterprise Value
3.21T
Revenue
399.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
50,300.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.76T, a decrease of -70.90%. That is a compound annual growth rate of -25.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 27, 2025 | 3,761.72B | -4.74% |
Dec 30, 2024 | 3,948.70B | -28.57% |
Dec 28, 2023 | 5,528.45B | -2.04% |
Dec 29, 2022 | 5,643.63B | -67.21% |
Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 71.46T |
Celltrion | 35.49T |
ALTEOGEN | 20.84T |
Yuhan | 7,589.05B |
SK Biopharmaceuticals | 7,236.14B |
HLB Co., Ltd. | 6,512.41B |
PharmaResearch | 4,992.23B |
Peptron | 4,741.01B |